Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bugufuran capsules for generalized anxiety disorder
CTR20161041Phase 2Completed
- Sponsor
- Shanghai Institute of Materia Medica
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of buagafuran in generalized anxiety disorder (GAD), sponsored by Shanghai Institute of Materia Medica. Started Dec 2016; status: completed.
02
Drugs
buagafuran
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on CTR20161041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20161041.